Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Herantis Pharma HRNTS Aug 3, 2020 86.40 -1.59   
 Hexagon B HEXAB Aug 3, 2020 585.40 +2.92   
 Hexagon Composites HEXO Aug 3, 2020 46.40 0.00   
 Hexatronic Group HTRO Aug 3, 2020 58.00 +3.20   
 Hexpol B HPOLB Aug 3, 2020 59.30 +1.89   
 Hiddn Solutions HIDDNO Aug 3, 2020 1.55 0.00   
 Hifab B HIFAB Aug 3, 2020 2.16 0.00   
 HiQ International HIQ Aug 3, 2020 53.40 +0.95   
 HMS Networks HMS Aug 3, 2020 199.60 +1.94   
 Hofseth BioCare HBCO Aug 3, 2020 8.20 0.00   
 Hoist Finance HOFI Aug 3, 2020 29.22 +4.81   
 Holmen A HOLMA Aug 3, 2020 390.00 -1.02   
 Holmen B HOLMB Aug 3, 2020 303.40 +1.20   
 HomeMaid B HOMEB Aug 3, 2020 5.68 +1.79   
 Hoodin HOODIN Aug 3, 2020 5.25 +5.21   
 Hoylu HOYLU Aug 3, 2020 1.74 -0.29   
 Hubso Group HUBSO Aug 3, 2020 1.10 0.00   
 Hudya HUDYA Aug 3, 2020 1.35 0.00   
 Hufvudstaden A HUFVA Aug 3, 2020 112.10 -1.49   
 Humana HUM Aug 3, 2020 52.30 -0.95   
 Hunter Group HUNTO Aug 3, 2020 3.25 0.00   
 Husqvarna A HUSQA Aug 3, 2020 85.60 +3.13   
 Husqvarna B HUSQB Aug 3, 2020 85.80 +2.75   
 Hybricon HYCO Aug 3, 2020 0.14 +3.68   
 Hästkällaren Rid Trav HSTKB Aug 3, 2020 8.75 +6.71   
 Höegh LNG Holdings HLNGO Aug 3, 2020 11.64 0.00   
 Hövding Sverige HOVD Aug 3, 2020 24.75 +1.23   
 I-tech ITECH Aug 3, 2020 105.00 +1.45   
 I.A.R Systems Group B IARB Aug 3, 2020 129.60 -1.82   
 IA Industriarmatur Group IAG Aug 3, 2020 10.50 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK